Contest Trader

Don't miss the chance to cash-in prizes totaling

$10.000
Register here for the Ultimate demo trading competition

A potential vaccine made the markets go round - Tuesday Review, August 25

A potential vaccine made the markets go round - Tuesday Review, August 25

The global markets were high on hope

The US

The benchmarks have been pushed higher by a possible COVID-19 #vaccine and Jerome Powell's speech due on Thursday. USA30 fell 0.21%, while USA500 rose 0.36%. TECH100 closed at an all-time high after it gained 0.76%.

#Oil prices reached their highest level in almost six months as Hurricane Laura nearly hit a couple of refineries in the US. Crude Oil added 1.9% to $43.56 per barrel, while Brent inched up 1.6% to $46.39.

Gold settled down 0.8% at $1,923.10 per ounce.

The Dollar Index fell by 0.2% at 93.061.

Asia and Australia

The stocks were boosted by the records reached by the American benchmarks amid the possible #COVID-19 vaccine.

Japan225 reached a six-month high after it added 1.35%.

HongKong45 lost 0.17% after a man was found positive for COVID-19 for the second time, confirming, therefore, the hypothesis that reinfection is possible.

Australia200 gained 0.50% even though the Commonwealth Bank of Australia painted a bleak picture of the post-pandemic economic recovery.

USD/JPY was up 0.20% to 106.19.

Europe

The markets followed its peers steps and ended the day on positive territory. Europe50 was up 0.4%, while UK100 added 0.3%. Germany30 rose 0.6%.

EUR/USD traded 0.4% higher at $1.18325.

Sources: reuters.com, investing.com

This information prepared by za.capex.com is not an offer or a solicitation for the purpose of purchase or sale of any financial products referred to herein or to enter into any legal relations, nor an advice or a recommendation with respect to such financial products.

This information is prepared for general circulation. It does not regard to the specific investment objectives, financial situation or the particular needs of any recipient.

You should independently evaluate each financial product and consider the suitability of such a financial product, by taking into account your specific investment objectives, financial situation or particular needs, and by consulting an independent financial adviser as needed, before dealing in any financial products mentioned in this document.

This information may not be published, circulated, reproduced or distributed in whole or in part to any other person without the Company’s prior written consent. Past performance is not always indicative of likely or future performance. Any views or opinions presented are solely those of the author and do not necessarily represent those of za.capex.com